Troy Asset Management’s Texas Instruments TXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.2M Sell
166,043
-14,824
-8% -$3M 0.96% 15
2025
Q4
$31.4M Sell
180,867
-1,997
-1% -$342K 0.81% 20
2025
Q3
$33.6M Buy
182,864
+10,733
+6% +$2.1M 0.86% 20
2025
Q2
$35.7M Hold
172,131
0.98% 20
2025
Q1
$35.7M Buy
172,131
+36,140
+27% +$6.77M 0.98% 20
2024
Q4
$25.5M Sell
135,991
-47,221
-26% -$9.44M 0.84% 26
2024
Q3
$37.8M Sell
183,212
-14,828
-7% -$2.98M 1.19% 22
2024
Q2
$38.5M Sell
198,040
-27,915
-12% -$5.16M 1.25% 20
2024
Q1
$39.4M Buy
225,955
+4,653
+2% +$776K 1.19% 20
2023
Q4
$37.7M Sell
221,302
-4,966
-2% -$769K 1.2% 21
2023
Q3
$36M Sell
226,268
-2,853
-1% -$487K 1.13% 22
2023
Q2
$41.2M Buy
229,121
+10,690
+5% +$1.84M 1.21% 21
2023
Q1
$40.6M Buy
218,431
+3,520
+2% +$619K 1.2% 21
2022
Q4
$35.5M Buy
+214,911
New +$35.8M 0.99% 21

Other funds holding TXN

Troy Asset Management's TXN Position: Q1 2026 in Review

Troy Asset Management reduced its Texas Instruments (TXN) stake by 8.2% in Q1 2026, selling an estimated $3M and leaving 166,043 shares worth $32.2M. The position accounts for 0.96% of the portfolio, ranked #15.

Troy Asset Management first reported a position in TXN in Q4 2022 and has held it in 14 quarters since. The position peaked at $41.2M in Q2 2023. 2,442 funds tracked by Wall St. Rank hold TXN as of Q1 2026.

  • Troy Asset Management held 166,043 shares of Texas Instruments worth $32.2M as of Q1 2026.
  • Troy Asset Management sold 14,824 Texas Instruments shares in Q1 2026, an estimated $3M.
  • Texas Instruments made up 0.96% of Troy Asset Management's portfolio in Q1 2026, its #15 holding.
  • Troy Asset Management first reported a position in Texas Instruments in Q4 2022 and has held it in 14 quarters since.
  • Troy Asset Management's Texas Instruments position peaked at $41.2M in Q2 2023.
  • 2,442 funds tracked by Wall St. Rank held Texas Instruments as of Q1 2026.

Based on Troy Asset Management's 13F filing for Q1 2026, filed 11 May 2026.